Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy
المؤلف | Konje, Justin C. |
المؤلف | Al Beloushi, Mariam |
المؤلف | Ahmed, Badreldeen |
تاريخ الإتاحة | 2024-05-14T07:53:28Z |
تاريخ النشر | 2023-02-24 |
اسم المنشور | Viruses |
المعرّف | http://dx.doi.org/10.3390/v15030621 |
الاقتباس | Konje, J. C., Al Beloushi, M., & Ahmed, B. (2023). Immunisation against COVID-19 in pregnancy and of women planning pregnancy. Viruses, 15(3), 621. |
الملخص | Following reports of the first human SARS-CoV2 infection in December 2019 from Wuhan Province, China, there was such rapid spread that by March 2021, the World Health Organization (WHO) had declared a pandemic. Over 6.5 million people have died from this infection worldwide, although this is most likely an underestimate. Until vaccines became available, mortality and severe morbidity were costly in terms of life lost as well as the cost of supporting the severely and acutely ill. Vaccination changed the landscape, and following worldwide adoption, life has gradually been returning to normal. The speed of production of the vaccines was unprecedented and undoubtedly ushered in a new era in the science of fighting infections. The developed vaccines were on the already known platforms for vaccine delivery: inactivated virus, virus vector, virus-like particles (VLP) subunit, DNA and mRNA. The mRNA platform was used for the first time to deliver vaccines to humans. An understanding of these platforms and the pros and cons of each are important for clinicians who are often challenged by the recipients on the advantages and risks of these vaccines. These vaccines have so far and reassuringly been shown to be safe in reproduction (with no effect on gametes) and pregnancy (not associated with congenital malformations). However, safety remains paramount and continuing vigilance is critical, especially against rare fatal complications such as vaccine-induced thrombocytopenia and myocarditis. Finally, the waning immunity months after vaccination means repeated immunisation is likely to be ongoing, but just how often and how many such revaccinations should be recommended remains uncertain. Research into other vaccines and alternate delivery methods should continue as this infection is likely to be around for a long time. |
اللغة | en |
الناشر | Multidisciplinary Digital Publishing Institute (MDPI) |
الموضوع | COVID-19 pregnancy reproduction severe acute respiratory syndrome (SARS) Coronavirus-2 (SARS-CoV-2) vaccination |
النوع | Article |
رقم العدد | 3 |
رقم المجلد | 15 |
ESSN | 1999-4915 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث فيروس كورونا المستجد (كوفيد-19) [808 items ]
-
أبحاث الطب [1412 items ]